Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in East Brunswick, New Jersey · 557 CRANBURY RD, SUITE 2, EAST BRUNSWICK, NJ 08816-5419 · (732) 254-6644
Part of Exelixis Clinical
As of July 2026, 1 paid clinical trial is recruiting at Exelixis Clinical in East Brunswick, New Jersey. Active studies at this site cover conditions such as Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC) and Head and Neck Squamous Cell Carcinoma (HNSCC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (1)
More research sites in East Brunswick
- Astera Cancer Care (19 trials)
- START New Jersey (6 trials)
- Astera Cancer Care East Brunswick (4 trials)
- START Astera, LLC (3 trials)
- Astera Cancer Care - 1128 (1 trial)
- Astera Cancer Care - East Brunswick (1 trial)
- East Brunswick Surgery Center (1 trial)
- GSK Investigational Site (1 trial)
- RWJ Cardiac Rehab at East Brunswick (1 trial)
- RWJ Endosurgical Center (1 trial)
Explore more
Paid clinical trials in East Brunswick, NJ · New Jersey clinical trials